Jeff Coyne
Vorstandsvorsitzender bei Provect Technologies, Inc.
Profil
Jeffrey C.
Coyne is currently the Chairman & Chief Executive Officer at Provect Technologies, Inc. He is also a Director at Transmed7 LLC and a Principal at CPR Turnaround LLC.
Previously, he was the Chairman of iFabric Corp.
from 2011 to 2020 and a Director at Ezenet Corp.
He received his undergraduate degree from the University of California, Berkeley and his graduate degree from Duke University School of Law.
Aktive Positionen von Jeff Coyne
| Unternehmen | Position | Beginn |
|---|---|---|
Provect Technologies, Inc.
 Provect Technologies, Inc. Packaged SoftwareTechnology Services Provect Technologies, Inc. develops and installs employee management systems. It provides employee scheduling and time management systems. The firm's products enable organizations to track labor data and manager resources in real-time. The company was founded in 2002 and is headquartered in Oak Park, IL. | Vorstandsvorsitzender | 01.01.2002 |
| CPR Turnaround LLC | Corporate Officer/Principal | - |
Transmed7 LLC
 Transmed7 LLC Medical SpecialtiesHealth Technology Transmed7 LLC is a medical and technology-based organization that focuses on developing innovative, minimally-invasive medical devices for doctors and their patients. The private company is based in Phoenix, AZ. The company's portfolio of next-generation platform devices is expected to be market leaders in oncology, regenerative medicine, and cardiovascular disease. Transmed7's business plan and structure enable these new transformational technologies to move from rapid development through commercial manufacturing and market deployment. The company's transformational forward-coring, zero5 biopsy devices improve patient care with broad applications to breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, bone marrow, and more. The company was founded in 2010 by Eugene H. Vetter, James W. Vetter. Eugene H. Vetter has been the CEO since 2010. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jeff Coyne
| Unternehmen | Position | Ende |
|---|---|---|
| IFABRIC CORP. | Vorsitzender | 01.04.2020 |
| Ezenet Corp. | Direktor/Vorstandsmitglied | - |
Ausbildung von Jeff Coyne
| University of California, Berkeley | Undergraduate Degree |
| Duke University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IFABRIC CORP. | Consumer Non-Durables |
| Private Unternehmen | 4 |
|---|---|
| Ezenet Corp. | Technology Services |
Provect Technologies, Inc.
Provect Technologies, Inc. Packaged SoftwareTechnology Services Provect Technologies, Inc. develops and installs employee management systems. It provides employee scheduling and time management systems. The firm's products enable organizations to track labor data and manager resources in real-time. The company was founded in 2002 and is headquartered in Oak Park, IL. | Technology Services |
| CPR Turnaround LLC | |
Transmed7 LLC
Transmed7 LLC Medical SpecialtiesHealth Technology Transmed7 LLC is a medical and technology-based organization that focuses on developing innovative, minimally-invasive medical devices for doctors and their patients. The private company is based in Phoenix, AZ. The company's portfolio of next-generation platform devices is expected to be market leaders in oncology, regenerative medicine, and cardiovascular disease. Transmed7's business plan and structure enable these new transformational technologies to move from rapid development through commercial manufacturing and market deployment. The company's transformational forward-coring, zero5 biopsy devices improve patient care with broad applications to breast, soft tissue, endoscopy, laparoscopy, robotics, vascular, bone marrow, and more. The company was founded in 2010 by Eugene H. Vetter, James W. Vetter. Eugene H. Vetter has been the CEO since 2010. | Health Technology |